In 1988, Wheeler et al. [8] reported that physicians treating patients for pulmonary embolism and deep-vein thrombosis frequently underdosed their patients and were slow to change their heparin ...
18F-Fluorodeoxyglucose Positron Emission Tomography Contributes to the Diagnosis and Management of Infections in Patients With Multiple Myeloma: A Study of 165 Infectious Episodes Two hundred and ...
A pooled analysis of individual patient data from the major bivalirudin versus unfractionated heparin trials concludes that preprocedural bivalirudin could be considered the agent of choice in the ...
New low concentration options in Freeflex ® IV bags join broadest portfolio of heparin sodium therapies LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced in the ...
Interventional cardiologists in the United States vary widely in their antithrombotic therapy preferences for primary PCI patients, according to new survey data. In a nine-question survey sent to ...
A new study could change the treatment course for hundreds of thousands of patients, saving lives and preventing complications. Bivalirudin is a safer and more effective anticoagulant than heparin for ...
The need for different heparin dosing protocols for obese and nonobese patients was studied. A chart review was performed for all patients who received heparin over an eightmonth period at an acute ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced in the United States two new presentations of Heparin Sodium in convenient, ready-to-administer Freeflex ® IV bags.
Bivalirudin is a safer and more effective anticoagulant than heparin for treating patients with the most serious type of heart attacks who undergo urgent percutaneous coronary intervention (PCI), and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results